A retired Army officer in his early 60s comes into the Warner Robins clinic frustrated. He has been on a thoughtful TRT protocol for two years. His total testosterone is 850, his free testosterone is in the upper third of the range, his estradiol is well-managed, his sleep is reasonable. By any standard hormone panel, he should feel great. He does not. His memory has slipped in a way that bothers him. He feels emotionally flat. His anxiety in crowds — something he never used to have — has crept up over the past year. His prior provider told him his labs were perfect and he should be happy. He is not happy, and he is not crazy, and the missing piece is almost certainly upstream of testosterone.
This is one of the situations where pregnenolone enters the conversation. Pregnenolone is the most upstream steroid hormone in the body — every other steroid hormone is built from it — and it is also one of the most potent neurosteroids the brain produces. When testosterone optimization alone is not getting a patient where they want to be, pregnenolone is one of the first things I check.
What pregnenolone actually is and why it earned the "mother hormone" label
Pregnenolone is synthesized in the mitochondria of the adrenal cortex, the gonads, and importantly the brain itself, from cholesterol via the enzyme CYP11A1 — also called the cholesterol side-chain cleavage enzyme. This is the rate-limiting step of all steroid hormone production in the body. Once pregnenolone exists, it can travel down two main pathways: into the progesterone arm of steroidogenesis (which then branches into corticosteroids and mineralocorticoids), or into the 17-hydroxypregnenolone arm (which leads to DHEA, androgens, and ultimately the sex hormones).
The "mother hormone" label is biochemically accurate. Cortisol comes from pregnenolone. Aldosterone comes from pregnenolone. Progesterone, DHEA, testosterone, estradiol — all of them are downstream of pregnenolone. When pregnenolone is low, the entire downstream cascade has less raw material to work with.
What makes pregnenolone clinically interesting beyond its precursor role is that it is independently active in the brain as a neurosteroid. Pregnenolone and its sulfated form, pregnenolone sulfate, modulate the NMDA glutamate receptor (positive modulation, which supports memory consolidation and learning) and the GABA-A receptor (negative modulation in some configurations, positive in others, depending on the regional brain location). The downstream metabolite allopregnanolone is one of the most potent positive GABA-A modulators in human physiology and is the active ingredient in the FDA-approved postpartum depression drug brexanolone.
In plain language: pregnenolone affects mood, anxiety, memory, focus, and stress resilience through direct brain effects, separate from anything it does as a hormone precursor. That dual role is why I see it produce changes in patients that pure sex hormone optimization does not.
How pregnenolone declines and why mid-life patients feel it
Like DHEA, pregnenolone production declines with age. The decline is gradual and usually clinically silent until it stacks with other mid-life shifts. By age 60, circulating pregnenolone is often 30-60% of its peak. The brain takes the hit harder than the rest of the body because the brain depends on pregnenolone for its own neurosteroid synthesis, and brain pregnenolone levels are not always reflected in the serum value we measure on a draw.
The pregnenolone steal is the other relevant mechanism, and it is the one I see most often in practice. Under chronic stress, the cortisol pathway pulls pregnenolone preferentially. The body shunts available pregnenolone toward cortisol production at the expense of the DHEA and sex hormone arms. Over months to years of unrelenting stress, the result is a patient with adequate cortisol output, depleted DHEA, depleted sex hormones, and depleted neurosteroid reserves — exactly the profile I see in the high-stress middle Georgia patients I work with most often: military personnel deploying repeatedly, first responders, business owners running on too little sleep, mothers caring for aging parents and teenagers simultaneously.
These patients arrive feeling burned out in a way that no single hormone replacement fully addresses. Restoring sex hormones helps, but the cognitive and emotional flatness often does not lift fully until the upstream pool is rebuilt.
What I look for clinically before considering pregnenolone
When I evaluate a patient for pregnenolone supplementation, I am looking for a specific pattern. The serum pregnenolone is helpful but imperfect — it does not capture brain pregnenolone, and the assay variability across labs is significant. I want pregnenolone in context with DHEA-S, the morning cortisol, the cortisol pattern across the day if a salivary or DUTCH panel is available, the full sex hormone panel, and the thyroid panel.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
The clinical picture I am looking for: a patient whose sex hormones are either being adequately replaced or are in a reasonable range on their own, but who continues to report cognitive symptoms (word-finding difficulty, working memory weakness, slowed processing), emotional flatness, anhedonia, anxiety that does not match life circumstances, poor stress resilience, or sleep that is technically sufficient but not restorative. A history of prolonged stress, traumatic brain injury (which depletes brain neurosteroids and is relevant for the veterans I see from Fort Benning), chronic insomnia, or long-term SSRI exposure all increase my pretest probability that pregnenolone deficiency is contributing.
I am also looking at what we have already done. If a male patient is on properly dosed men's testosterone replacement and a female patient is on properly dosed hormone optimization — and they are still describing the cognitive and emotional symptoms above — that is when pregnenolone moves from theoretical to actionable.
How I dose and what to watch for
The dosing of pregnenolone has been overcorrected in both directions in the supplement world. Older protocols pushed 100 to 200 mg, which is far more than most patients need and reliably produces side effects. The opposite extreme — very low doses that cannot move the needle — is also common.
In my practice, the typical starting dose for an adult is 10 to 25 mg in the morning, taken with food. A subset of patients respond well to a smaller second dose in the early afternoon. I rarely start above 25 mg. The reason for the conservatism is the same reason as with DHEA — pregnenolone is a precursor, and its conversion downstream is variable. In some patients, supplemental pregnenolone preferentially feeds the cortisol arm and produces wired-but-tired symptoms, anxiety, or sleep disruption. In others, it feeds the DHEA and sex hormone arms and produces androgenic effects similar to DHEA, including acne, scalp hair shedding, or menstrual changes in premenopausal women. In still others, it feeds neurosteroid synthesis and the patient simply feels mentally clearer with better stress tolerance and better sleep.
I recheck pregnenolone, DHEA-S, total and free testosterone, estradiol, and the cortisol pattern at six to eight weeks. If symptoms have improved and the labs confirm the supplementation has shifted the pool in a useful direction, we hold the dose. If the conversion has gone somewhere unhelpful, we adjust — sometimes that means lowering the dose, sometimes splitting it, sometimes stopping pregnenolone and addressing the upstream stress physiology with adrenal support, sleep correction, or in some cases targeted therapy referral.
Pregnenolone is not a chronic high-dose supplement in my practice. It is a precise, monitored intervention layered into a broader hormone protocol when the clinical and lab picture support it.
When pregnenolone is not the answer
I redirect patients away from pregnenolone when the symptom picture is better explained by another mechanism. Untreated thyroid dysfunction can mimic the same cognitive and emotional pattern. Untreated sleep apnea will produce the same flat, brain-foggy presentation regardless of any hormone we replace. Active depression that warrants psychiatric evaluation should not be substituted with a precursor hormone. Significant adrenal insufficiency that warrants endocrinology workup should not be self-treated with pregnenolone. And patients on hormone-sensitive cancer surveillance should not be given precursor hormones without coordination with their oncology team.
I am also cautious in patients who have had paradoxical or strongly negative responses to similar hormones in the past. A history of severe progesterone intolerance, for example, can predict difficulty tolerating pregnenolone because of the shared downstream metabolites.
What I want you to do next
If pregnenolone is something you have read about and are wondering whether it applies to you, the next step is the comprehensive lab work panel and a real conversation, not a bottle off the shelf. Pregnenolone is one of the more interesting tools in the hormone optimization toolkit and one of the easier ones to misuse without monitoring.
Bring your prior labs, a list of any current supplements with exact doses, and an honest description of which symptoms have not responded to whatever you have already tried. Schedule the consultation at the Columbus location or the Warner Robins location. We will look at where pregnenolone fits — or does not fit — in your specific physiology, and build the protocol from there. The mother hormone is not for everyone. When it is the right tool, used at the right dose, with the right monitoring, the patients who needed it tend to know within the first six weeks.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.